FDA unveils new user fee pricing; Allergan reports jump in device sales;

Medical Device News

 @FierceMedDev: Cool science news: researchers have developed a mechanosensor that could be used for biomed sensing and artifical skin. More | Follow @FierceMedDev

 @MarkHFierce: The use of transcatheter aortic valve implants may be based on shaky evidence. More | Follow @MarkHFierce

 @DamianFierce: After closing its $241M Medtox acquisition, LabCorp denies it's a buyout target. Article | Follow @DamianFierce

> The FDA has released its 2013 medical device review pricing structures, now made official by the latest renewal of the Medical Device User Fee Act. Item

> Allergan ($AGN) says net sales of its medical devices jumped 4% during its 2012 second quarter, or 8.7% on a constant currency basis. Overall, the company generated more than $1.46 billion in net sales during the quarter, 4.8% higher than the same period last year. Release

> Navidea Biopharmaceuticals has inked a deal with Alseres Pharmaceuticals to license a new imaging agent designed to help diagnose Parkinson's disease and other movement disorders. Release

> On the heels of news that Cook Medical has scrapped expansion plans to prepare for the 2.3% medical device tax, Indiana's News-Sentinel says the state will be particularly affected by the charge. Editorial

> Echo Therapeutics ($ECTE) says it has achieved positive clinical results using its needle-free, non-invasive, wireless transdermal continuous glucose monitoring system in major general surgery and cardiothoracic surgery patients. Release

> Medical device marketers can engage physicians digitally in many more ways than they used to not that long ago, according to one of the speakers at the 2nd Annual Digital Marketing of Medical Devices Conference in Minneapolis. Story

Biotech News

 @FierceBiotech: Medidata lands record $100M deal with a Big Pharma. More | Follow @FierceBiotech

 @JohnCFierce: Can a new Pfizer find success in its long-struggling R&D division? More | Follow @JohnCFierce

 @RyanMFierce: Call me skeptical. Moncef Slaoui wants to jump-start pharma innovation, use bioelectronics to treat disease. More | Follow @RyanMFierce

> The top 15 biotech venture investments in H1 2012. Report

> Adimab, Mersana strike deal to make antibody-drug combos for pharma. News

> Buzz: Avalon Ventures passes the hat on $200M biotech fund. Article

> Can a new Pfizer find success in its long-struggling R&D division? More

> Pfizer faces delay on tofacitinib as new data adds blockbuster luster. Story

Pharma News

 @FiercePharma:  Patent cliff news that's good for the NHS, not so much for pharma: U.K. scripts up, costs down--ReutersMore | Follow @FiercePharma

> Bayer settles Yasmin suits for $212K each, $402M total. More

> Lupin eyes buyouts up to $500M in U.S. growth push. News

> Proxy firm backs half of Icahn's Forest nominees. Story

Drug Delivery News

> $27M funding will help advance Mersana's ADC pipeline. Story

> InSite Vision starts Phase III for post-surgery eye pain treatment. Article

> Israeli government invests $11M in nanodelivery. News

Biomarkers News 

> GSK to leave phenomenal Olympic legacy for biomarker research. News

> LifeCodexx gets go ahead for Down syndrome test in Switzerland. Story

> Genetic mutation behind rare childhood paralysis. Article

> Gene fusion signposts aggressive brain cancer. More

Suggested Articles

Boehringer Ingelheim tapped Healx to help identify new drug indications and leverage its AI to explore R&D options in neurological diseases.

CMR Surgical will have a new CEO at the top of the year, as it kicks off the global launch of its modular Versius system while awaiting FDA approval.

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.